Completed
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
NCT01764633
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Birmingham, Alabama, United States
- Research Site Huntsville, Alabama, United States
- Research Site Mobile, Alabama, United States